Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2012 by Samsung Medical Center.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Medipost Co Ltd.
Information provided by (Responsible Party):
Duk Lyul Na, Samsung Medical Center
ClinicalTrials.gov Identifier:
NCT01696591
First received: September 7, 2012
Last updated: September 27, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)